nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP2D6—Parkinson's disease	0.42	0.583	CbGaD
Methadone—ABCB1—Parkinson's disease	0.3	0.417	CbGaD
Methadone—HTR3A—enteric nervous system—Parkinson's disease	0.0201	0.192	CbGeAlD
Methadone—HTR3A—myenteric nerve plexus—Parkinson's disease	0.0153	0.146	CbGeAlD
Methadone—OPRM1—telencephalic ventricle—Parkinson's disease	0.00578	0.0552	CbGeAlD
Methadone—HTR3A—nerve—Parkinson's disease	0.00398	0.0379	CbGeAlD
Methadone—OPRM1—nerve—Parkinson's disease	0.00365	0.0348	CbGeAlD
Methadone—GRIN3A—forebrain—Parkinson's disease	0.00314	0.03	CbGeAlD
Methadone—OPRD1—forebrain—Parkinson's disease	0.00221	0.0211	CbGeAlD
Methadone—OPRK1—forebrain—Parkinson's disease	0.00212	0.0203	CbGeAlD
Methadone—CHRNA10—head—Parkinson's disease	0.00204	0.0194	CbGeAlD
Methadone—GRIN3A—head—Parkinson's disease	0.0018	0.0172	CbGeAlD
Methadone—HTR3A—brainstem—Parkinson's disease	0.00171	0.0163	CbGeAlD
Methadone—GRIN3A—nervous system—Parkinson's disease	0.00171	0.0163	CbGeAlD
Methadone—HTR3A—forebrain—Parkinson's disease	0.00165	0.0157	CbGeAlD
Methadone—GRIN3A—central nervous system—Parkinson's disease	0.00164	0.0157	CbGeAlD
Methadone—OPRM1—brainstem—Parkinson's disease	0.00156	0.0149	CbGeAlD
Methadone—OPRM1—forebrain—Parkinson's disease	0.00151	0.0144	CbGeAlD
Methadone—GRIN3A—brain—Parkinson's disease	0.0013	0.0124	CbGeAlD
Methadone—CYP19A1—forebrain—Parkinson's disease	0.00127	0.0121	CbGeAlD
Methadone—OPRD1—head—Parkinson's disease	0.00127	0.0121	CbGeAlD
Methadone—OPRK1—head—Parkinson's disease	0.00122	0.0116	CbGeAlD
Methadone—OPRD1—nervous system—Parkinson's disease	0.0012	0.0115	CbGeAlD
Methadone—OPRD1—central nervous system—Parkinson's disease	0.00116	0.011	CbGeAlD
Methadone—OPRK1—nervous system—Parkinson's disease	0.00115	0.011	CbGeAlD
Methadone—OPRK1—central nervous system—Parkinson's disease	0.00111	0.0106	CbGeAlD
Methadone—CYP2D6—hindbrain—Parkinson's disease	0.00109	0.0104	CbGeAlD
Methadone—OPRK1—cerebellum—Parkinson's disease	0.00108	0.0104	CbGeAlD
Methadone—Alverine—HTR1A—Parkinson's disease	0.00101	0.104	CrCbGaD
Methadone—OPRM1—midbrain—Parkinson's disease	0.000997	0.00952	CbGeAlD
Methadone—OPRM1—spinal cord—Parkinson's disease	0.000973	0.00929	CbGeAlD
Methadone—HTR3A—head—Parkinson's disease	0.000943	0.009	CbGeAlD
Methadone—OPRD1—brain—Parkinson's disease	0.000919	0.00877	CbGeAlD
Methadone—HTR3A—nervous system—Parkinson's disease	0.000894	0.00853	CbGeAlD
Methadone—OPRK1—brain—Parkinson's disease	0.000881	0.00841	CbGeAlD
Methadone—OPRM1—head—Parkinson's disease	0.000865	0.00825	CbGeAlD
Methadone—HTR3A—central nervous system—Parkinson's disease	0.000861	0.00822	CbGeAlD
Methadone—Benzphetamine—SLC18A2—Parkinson's disease	0.000836	0.0861	CrCbGaD
Methadone—OPRM1—nervous system—Parkinson's disease	0.00082	0.00782	CbGeAlD
Methadone—OPRM1—central nervous system—Parkinson's disease	0.000789	0.00753	CbGeAlD
Methadone—CYP19A1—head—Parkinson's disease	0.000727	0.00693	CbGeAlD
Methadone—CYP2B6—cardiovascular system—Parkinson's disease	0.000689	0.00658	CbGeAlD
Methadone—CYP19A1—nervous system—Parkinson's disease	0.000689	0.00657	CbGeAlD
Methadone—HTR3A—brain—Parkinson's disease	0.000684	0.00652	CbGeAlD
Methadone—CYP2C9—cardiovascular system—Parkinson's disease	0.000682	0.00651	CbGeAlD
Methadone—CYP19A1—central nervous system—Parkinson's disease	0.000663	0.00633	CbGeAlD
Methadone—CYP2D6—brainstem—Parkinson's disease	0.000627	0.00599	CbGeAlD
Methadone—OPRM1—brain—Parkinson's disease	0.000627	0.00598	CbGeAlD
Methadone—CYP2D6—forebrain—Parkinson's disease	0.000606	0.00578	CbGeAlD
Methadone—CYP19A1—brain—Parkinson's disease	0.000527	0.00502	CbGeAlD
Methadone—ABCB1—embryo—Parkinson's disease	0.000492	0.0047	CbGeAlD
Methadone—CYP2B6—head—Parkinson's disease	0.000467	0.00445	CbGeAlD
Methadone—CYP2B6—nervous system—Parkinson's disease	0.000442	0.00422	CbGeAlD
Methadone—Trospium—CYP2D6—Parkinson's disease	0.000441	0.0454	CrCbGaD
Methadone—ABCB1—forebrain—Parkinson's disease	0.000436	0.00416	CbGeAlD
Methadone—CYP2B6—central nervous system—Parkinson's disease	0.000426	0.00406	CbGeAlD
Methadone—Modafinil—SLC6A3—Parkinson's disease	0.0004	0.0412	CrCbGaD
Methadone—CYP2C8—brain—Parkinson's disease	0.000377	0.0036	CbGeAlD
Methadone—Tripelennamine—CYP2D6—Parkinson's disease	0.00037	0.0381	CrCbGaD
Methadone—ABCB1—cardiovascular system—Parkinson's disease	0.000368	0.00351	CbGeAlD
Methadone—Benzphetamine—SLC6A3—Parkinson's disease	0.000347	0.0357	CrCbGaD
Methadone—CYP2D6—head—Parkinson's disease	0.000347	0.00331	CbGeAlD
Methadone—Atomoxetine—SLC6A3—Parkinson's disease	0.000344	0.0354	CrCbGaD
Methadone—Propiomazine—DRD1—Parkinson's disease	0.000341	0.0351	CrCbGaD
Methadone—CYP2B6—brain—Parkinson's disease	0.000338	0.00323	CbGeAlD
Methadone—CYP3A4—nervous system—Parkinson's disease	0.000334	0.00319	CbGeAlD
Methadone—CYP2D6—nervous system—Parkinson's disease	0.000329	0.00314	CbGeAlD
Methadone—Clotrimazole—CYP2E1—Parkinson's disease	0.000327	0.0337	CrCbGaD
Methadone—CYP3A4—central nervous system—Parkinson's disease	0.000322	0.00307	CbGeAlD
Methadone—Darifenacin—CYP2D6—Parkinson's disease	0.00032	0.0329	CrCbGaD
Methadone—CYP2D6—central nervous system—Parkinson's disease	0.000316	0.00302	CbGeAlD
Methadone—ABCB1—medulla oblongata—Parkinson's disease	0.000315	0.003	CbGeAlD
Methadone—Fexofenadine—CYP2D6—Parkinson's disease	0.000311	0.032	CrCbGaD
Methadone—CYP2D6—cerebellum—Parkinson's disease	0.000309	0.00295	CbGeAlD
Methadone—ABCB1—midbrain—Parkinson's disease	0.000288	0.00274	CbGeAlD
Methadone—Trimipramine—SLC6A3—Parkinson's disease	0.000283	0.0291	CrCbGaD
Methadone—ABCB1—spinal cord—Parkinson's disease	0.000281	0.00268	CbGeAlD
Methadone—CYP2D6—brain—Parkinson's disease	0.000251	0.0024	CbGeAlD
Methadone—ABCB1—head—Parkinson's disease	0.000249	0.00238	CbGeAlD
Methadone—Trimipramine—HTR1A—Parkinson's disease	0.000248	0.0255	CrCbGaD
Methadone—Propiomazine—DRD2—Parkinson's disease	0.000241	0.0248	CrCbGaD
Methadone—Clotrimazole—CYP2D6—Parkinson's disease	0.00024	0.0248	CrCbGaD
Methadone—ABCB1—nervous system—Parkinson's disease	0.000236	0.00226	CbGeAlD
Methadone—ABCB1—central nervous system—Parkinson's disease	0.000228	0.00217	CbGeAlD
Methadone—ABCB1—cerebellum—Parkinson's disease	0.000223	0.00212	CbGeAlD
Methadone—Fexofenadine—ABCB1—Parkinson's disease	0.000222	0.0229	CrCbGaD
Methadone—Trimipramine—DRD2—Parkinson's disease	0.00021	0.0217	CrCbGaD
Methadone—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.000208	0.0214	CrCbGaD
Methadone—Promethazine—DRD2—Parkinson's disease	0.000203	0.0209	CrCbGaD
Methadone—Loperamide—CYP2D6—Parkinson's disease	0.000198	0.0204	CrCbGaD
Methadone—Atomoxetine—HTR2A—Parkinson's disease	0.000198	0.0204	CrCbGaD
Methadone—Tamoxifen—CYP2E1—Parkinson's disease	0.000194	0.0199	CrCbGaD
Methadone—Orphenadrine—CYP2E1—Parkinson's disease	0.000188	0.0194	CrCbGaD
Methadone—Propiomazine—HTR2A—Parkinson's disease	0.000186	0.0191	CrCbGaD
Methadone—Atomoxetine—CYP2D6—Parkinson's disease	0.000181	0.0186	CrCbGaD
Methadone—ABCB1—brain—Parkinson's disease	0.000181	0.00172	CbGeAlD
Methadone—Clotrimazole—ABCB1—Parkinson's disease	0.000172	0.0177	CrCbGaD
Methadone—Trimipramine—HTR2A—Parkinson's disease	0.000163	0.0167	CrCbGaD
Methadone—Promethazine—HTR2A—Parkinson's disease	0.000157	0.0161	CrCbGaD
Methadone—Trimipramine—CYP2D6—Parkinson's disease	0.000149	0.0153	CrCbGaD
Methadone—Fentanyl—ABCB1—Parkinson's disease	0.000147	0.0151	CrCbGaD
Methadone—Diphenhydramine—CYP2D6—Parkinson's disease	0.000146	0.015	CrCbGaD
Methadone—Promethazine—CYP2D6—Parkinson's disease	0.000143	0.0147	CrCbGaD
Methadone—Tamoxifen—CYP2D6—Parkinson's disease	0.000142	0.0146	CrCbGaD
Methadone—Loperamide—ABCB1—Parkinson's disease	0.000141	0.0146	CrCbGaD
Methadone—Trimipramine—ABCB1—Parkinson's disease	0.000106	0.0109	CrCbGaD
Methadone—Promethazine—ABCB1—Parkinson's disease	0.000102	0.0105	CrCbGaD
Methadone—Tamoxifen—ABCB1—Parkinson's disease	0.000102	0.0105	CrCbGaD
Methadone—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.74e-05	0.000165	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTA4—Parkinson's disease	2.73e-05	0.000164	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	2.72e-05	0.000164	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.7e-05	0.000162	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IGF1R—Parkinson's disease	2.69e-05	0.000162	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—MTHFR—Parkinson's disease	2.66e-05	0.00016	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EDN1—Parkinson's disease	2.66e-05	0.00016	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	2.64e-05	0.000159	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.63e-05	0.000158	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—OMD—Parkinson's disease	2.63e-05	0.000158	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—NQO1—Parkinson's disease	2.62e-05	0.000157	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—DDC—Parkinson's disease	2.58e-05	0.000155	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—TH—Parkinson's disease	2.58e-05	0.000155	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	2.54e-05	0.000153	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—COMT—Parkinson's disease	2.52e-05	0.000152	CbGpPWpGaD
Methadone—ABCB1—Metabolism—DDC—Parkinson's disease	2.52e-05	0.000152	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GSTP1—Parkinson's disease	2.51e-05	0.000151	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—MAOA—Parkinson's disease	2.51e-05	0.000151	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.51e-05	0.000151	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.49e-05	0.00015	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—APOE—Parkinson's disease	2.48e-05	0.000149	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—HMOX1—Parkinson's disease	2.48e-05	0.000149	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYCS—Parkinson's disease	2.47e-05	0.000149	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	2.46e-05	0.000148	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	2.46e-05	0.000148	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	2.46e-05	0.000148	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NGF—Parkinson's disease	2.44e-05	0.000147	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	2.44e-05	0.000147	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.44e-05	0.000147	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MAOB—Parkinson's disease	2.44e-05	0.000147	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.41e-05	0.000145	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.38e-05	0.000143	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ABCB1—Parkinson's disease	2.38e-05	0.000143	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—DDC—Parkinson's disease	2.38e-05	0.000143	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.37e-05	0.000143	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	2.36e-05	0.000142	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—DDC—Parkinson's disease	2.36e-05	0.000142	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	2.33e-05	0.00014	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	2.33e-05	0.00014	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.32e-05	0.000139	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GSTM1—Parkinson's disease	2.31e-05	0.000139	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.24e-05	0.000135	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.24e-05	0.000135	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.22e-05	0.000134	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GPX1—Parkinson's disease	2.21e-05	0.000133	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	2.2e-05	0.000132	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.2e-05	0.000132	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—COMT—Parkinson's disease	2.19e-05	0.000132	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GSTP1—Parkinson's disease	2.18e-05	0.000131	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—MAOA—Parkinson's disease	2.18e-05	0.000131	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MAOB—Parkinson's disease	2.17e-05	0.000131	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—APOE—Parkinson's disease	2.16e-05	0.00013	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—HMOX1—Parkinson's disease	2.15e-05	0.000129	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.14e-05	0.000129	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NGF—Parkinson's disease	2.14e-05	0.000129	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	2.14e-05	0.000129	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MAOB—Parkinson's disease	2.12e-05	0.000128	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—INS—Parkinson's disease	2.12e-05	0.000127	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GBA—Parkinson's disease	2.12e-05	0.000127	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.12e-05	0.000127	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—DBH—Parkinson's disease	2.12e-05	0.000127	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CTGF—Parkinson's disease	2.1e-05	0.000126	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	2.09e-05	0.000126	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.07e-05	0.000124	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ABCB1—Parkinson's disease	2.06e-05	0.000124	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	2.06e-05	0.000124	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CTGF—Parkinson's disease	2.05e-05	0.000123	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	2.04e-05	0.000123	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—MTHFR—Parkinson's disease	2.04e-05	0.000123	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.02e-05	0.000122	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—DDC—Parkinson's disease	2.01e-05	0.000121	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GSTM1—Parkinson's disease	2e-05	0.000121	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2e-05	0.00012	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MAOB—Parkinson's disease	2e-05	0.00012	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	2e-05	0.00012	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.98e-05	0.000119	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	1.97e-05	0.000119	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	1.96e-05	0.000118	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—NQO1—Parkinson's disease	1.93e-05	0.000116	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GPX1—Parkinson's disease	1.92e-05	0.000115	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	1.91e-05	0.000115	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—TH—Parkinson's disease	1.91e-05	0.000115	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.9e-05	0.000114	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—APOE—Parkinson's disease	1.9e-05	0.000114	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—APOE—Parkinson's disease	1.9e-05	0.000114	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—NQO1—Parkinson's disease	1.89e-05	0.000114	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.89e-05	0.000113	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.88e-05	0.000113	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—TH—Parkinson's disease	1.86e-05	0.000112	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—INS—Parkinson's disease	1.85e-05	0.000111	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYCS—Parkinson's disease	1.83e-05	0.00011	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NGF—Parkinson's disease	1.81e-05	0.000109	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	1.81e-05	0.000109	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYCS—Parkinson's disease	1.79e-05	0.000108	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CTGF—Parkinson's disease	1.78e-05	0.000107	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—MTHFR—Parkinson's disease	1.77e-05	0.000107	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	1.72e-05	0.000104	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.71e-05	0.000103	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.69e-05	0.000102	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	1.66e-05	9.96e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—APOE—Parkinson's disease	1.65e-05	9.92e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NQO1—Parkinson's disease	1.64e-05	9.85e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—INS—Parkinson's disease	1.62e-05	9.76e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—COMT—Parkinson's disease	1.62e-05	9.75e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—INS—Parkinson's disease	1.62e-05	9.75e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.62e-05	9.72e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—TH—Parkinson's disease	1.61e-05	9.71e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTP1—Parkinson's disease	1.61e-05	9.7e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.61e-05	9.7e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—MAOA—Parkinson's disease	1.61e-05	9.68e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—APOE—Parkinson's disease	1.6e-05	9.64e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—HMOX1—Parkinson's disease	1.59e-05	9.57e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.59e-05	9.54e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—COMT—Parkinson's disease	1.58e-05	9.53e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.58e-05	9.49e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.58e-05	9.48e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.57e-05	9.46e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.55e-05	9.35e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—DDC—Parkinson's disease	1.55e-05	9.34e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYCS—Parkinson's disease	1.55e-05	9.32e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CTGF—Parkinson's disease	1.55e-05	9.31e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ABCB1—Parkinson's disease	1.53e-05	9.18e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.49e-05	8.98e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTM1—Parkinson's disease	1.48e-05	8.92e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.48e-05	8.89e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.47e-05	8.86e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.47e-05	8.82e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.46e-05	8.79e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.46e-05	8.78e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTM1—Parkinson's disease	1.45e-05	8.71e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.45e-05	8.7e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.44e-05	8.68e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—TH—Parkinson's disease	1.44e-05	8.66e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NQO1—Parkinson's disease	1.43e-05	8.58e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GPX1—Parkinson's disease	1.42e-05	8.54e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—INS—Parkinson's disease	1.41e-05	8.47e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—TH—Parkinson's disease	1.41e-05	8.46e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GPX1—Parkinson's disease	1.39e-05	8.35e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.38e-05	8.32e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	1.38e-05	8.28e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—COMT—Parkinson's disease	1.37e-05	8.25e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—INS—Parkinson's disease	1.37e-05	8.24e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	1.37e-05	8.22e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTP1—Parkinson's disease	1.37e-05	8.21e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MAOA—Parkinson's disease	1.36e-05	8.19e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.36e-05	8.18e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYCS—Parkinson's disease	1.35e-05	8.12e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.35e-05	8.11e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—HMOX1—Parkinson's disease	1.35e-05	8.1e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.34e-05	8.09e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.33e-05	8.02e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—TH—Parkinson's disease	1.32e-05	7.97e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.32e-05	7.94e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—TH—Parkinson's disease	1.31e-05	7.9e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—MTHFR—Parkinson's disease	1.31e-05	7.88e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.31e-05	7.86e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.29e-05	7.78e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.28e-05	7.7e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.27e-05	7.65e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	1.26e-05	7.61e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.26e-05	7.58e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.26e-05	7.57e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1.25e-05	7.55e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.24e-05	7.43e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—COMT—Parkinson's disease	1.22e-05	7.37e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOE—Parkinson's disease	1.22e-05	7.34e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.22e-05	7.33e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.22e-05	7.31e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	1.21e-05	7.26e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.2e-05	7.23e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GPX1—Parkinson's disease	1.2e-05	7.23e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	1.2e-05	7.21e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—COMT—Parkinson's disease	1.2e-05	7.19e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOE—Parkinson's disease	1.19e-05	7.17e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.19e-05	7.16e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MAOA—Parkinson's disease	1.19e-05	7.14e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.17e-05	7.06e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ABCB1—Parkinson's disease	1.15e-05	6.94e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.15e-05	6.93e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.14e-05	6.85e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—COMT—Parkinson's disease	1.13e-05	6.78e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TH—Parkinson's disease	1.12e-05	6.75e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.12e-05	6.74e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—Parkinson's disease	1.12e-05	6.74e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.12e-05	6.73e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—COMT—Parkinson's disease	1.12e-05	6.72e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.11e-05	6.69e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MTHFR—Parkinson's disease	1.11e-05	6.67e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	1.11e-05	6.67e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.11e-05	6.67e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.11e-05	6.65e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.1e-05	6.59e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.09e-05	6.58e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.08e-05	6.48e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GPX1—Parkinson's disease	1.07e-05	6.45e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.06e-05	6.38e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.05e-05	6.33e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GPX1—Parkinson's disease	1.05e-05	6.3e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—INS—Parkinson's disease	1.04e-05	6.27e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOE—Parkinson's disease	1.03e-05	6.21e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.03e-05	6.2e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.02e-05	6.14e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	1.02e-05	6.13e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—INS—Parkinson's disease	1.02e-05	6.13e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	1.01e-05	6.09e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MTHFR—Parkinson's disease	9.9e-06	5.95e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GPX1—Parkinson's disease	9.87e-06	5.93e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GPX1—Parkinson's disease	9.78e-06	5.88e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	9.72e-06	5.85e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MTHFR—Parkinson's disease	9.66e-06	5.81e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—COMT—Parkinson's disease	9.54e-06	5.74e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CTGF—Parkinson's disease	9.54e-06	5.74e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—Parkinson's disease	9.5e-06	5.71e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MAOA—Parkinson's disease	9.48e-06	5.7e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	9.37e-06	5.64e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HMOX1—Parkinson's disease	9.37e-06	5.63e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOE—Parkinson's disease	9.22e-06	5.54e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	9.11e-06	5.48e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MTHFR—Parkinson's disease	9.03e-06	5.43e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOE—Parkinson's disease	9e-06	5.41e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCB1—Parkinson's disease	8.99e-06	5.41e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	8.89e-06	5.35e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—INS—Parkinson's disease	8.82e-06	5.31e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NQO1—Parkinson's disease	8.79e-06	5.29e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—Parkinson's disease	8.73e-06	5.25e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TH—Parkinson's disease	8.66e-06	5.21e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOE—Parkinson's disease	8.48e-06	5.1e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOE—Parkinson's disease	8.4e-06	5.05e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GPX1—Parkinson's disease	8.36e-06	5.03e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYCS—Parkinson's disease	8.32e-06	5e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—Parkinson's disease	8.08e-06	4.86e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—INS—Parkinson's disease	7.87e-06	4.74e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MTHFR—Parkinson's disease	7.71e-06	4.64e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—INS—Parkinson's disease	7.68e-06	4.62e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—COMT—Parkinson's disease	7.36e-06	4.43e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.33e-06	4.41e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.31e-06	4.4e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—INS—Parkinson's disease	7.24e-06	4.36e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.23e-06	4.35e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOE—Parkinson's disease	7.18e-06	4.32e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—INS—Parkinson's disease	7.18e-06	4.32e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—Parkinson's disease	7.08e-06	4.26e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	6.94e-06	4.17e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	6.74e-06	4.05e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GPX1—Parkinson's disease	6.45e-06	3.88e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—INS—Parkinson's disease	6.13e-06	3.69e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—Parkinson's disease	5.99e-06	3.6e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.95e-06	3.58e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOE—Parkinson's disease	5.54e-06	3.33e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—INS—Parkinson's disease	4.73e-06	2.85e-05	CbGpPWpGaD
